Ranibizumab for treating diabetic macular oedema

Technology appraisal guidance
Reference number: TA274
Published: 27 February 2013
Last updated: 26 October 2023

TA274 Macular oedema (diabetic) - ranibizumab: appendix A - matrix of stakeholders

TA274 Macular oedema (diabetic) - ranibizumab: appendix A - matrix of stakeholders

TA274 Macular oedema (diabetic) - ranibizumab: appendix A - matrix of stakeholders
23 February 2015
(40.72 Kb 11 sec)

Adobe Acrobat reader required.

Adobe Acrobat reader required.

This page was last updated: 18 February 2015